A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer

NCT05187832 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Breast Cancer

Interventions

DRUG: AND019 PO QD

Sponsor

Kind Pharmaceuticals LLC